Earlier appearance of impaired insulin secretion than of visceral adiposity in the pathogenesis of NIDDM. 5-Year follow-up of initially nondiabetic Japanese-American men
- PMID: 7555498
- DOI: 10.2337/diacare.18.6.747
Earlier appearance of impaired insulin secretion than of visceral adiposity in the pathogenesis of NIDDM. 5-Year follow-up of initially nondiabetic Japanese-American men
Abstract
OBJECTIVE--To identify risk factors for development of non-insulin-dependent diabetes mellitus (NIDDM) during a 5-year longitudinal follow-up of second-generation Japanese-American (Nisei) men. RESEARCH DESIGN AND METHODS--For 5 years, 137 initially nondiabetic Nisei men were followed with 75-g oral glucose tolerance tests at the initial visit and at 2.5- and 5-year follow-up visits. Body fat distribution was assessed by computed tomography (CT) and body mass index (BMI) calculated at each visit. Fasting insulin and C-peptide, the increment of insulin and C-peptide at 30 min after the oral glucose load, intra-abdominal and total subcutaneous fat by CT, and BMI were compared between those who remained nondiabetic (non-DM) and those who had developed NIDDM at 2.5 years (DM-A) and 5 years (DM-B). RESULTS--At baseline, the DM-A group had significantly increased intra-abdominal fat, elevated fasting plasma C-peptide, and lower C-peptide response at 30 min after oral glucose. At the 2.5-year follow-up, this group had markedly increased fasting plasma insulin and decreased 30-min insulin and C-peptide response to oral glucose. The DM-B group also had significantly lower insulin response at 30 min after oral glucose at baseline but no significant difference in intra-abdominal fat or fasting plasma insulin and C-peptide levels. When this group developed NIDDM by 5-year follow-up, however, an increase of intra-abdominal fat was found superimposed on the pre-existing lower insulin response. Fasting plasma insulin and C-peptide remained low. CONCLUSION--In DM-A, lower 30-min insulin response to oral glucose (an indicator of beta-cell lesion) and increased intra-abdominal fat and fasting C-peptide (indicators of insulin resistance) were the risk factors related to the development of NIDDM. DM-B subjects had a lower 30-min insulin response to oral glucose at baseline and increased intra-abdominal fat at 5-years, when they were found to have NIDDM. Thus, both insulin resistance and impaired beta-cell function contribute to the development of NIDDM in Japanese-Americans, and impaired beta-cell function may be present earlier than visceral adiposity in some who subsequently develop NIDDM.
Similar articles
-
Study of genetic prediabetic south Indian subjects. Importance of hyperinsulinemia and beta-cell dysfunction.Diabetes Care. 1998 Jan;21(1):76-9. doi: 10.2337/diacare.21.1.76. Diabetes Care. 1998. PMID: 9538973
-
Association of elevated fasting C-peptide level and increased intra-abdominal fat distribution with development of NIDDM in Japanese-American men.Diabetes. 1990 Jan;39(1):104-11. doi: 10.2337/diacare.39.1.104. Diabetes. 1990. PMID: 2210052
-
Metabolic and adipose risk factors for NIDDM and coronary disease in third-generation Japanese-American men and women with impaired glucose tolerance.Diabetologia. 1994 May;37(5):524-32. doi: 10.1007/s001250050142. Diabetologia. 1994. PMID: 8056192
-
Impaired beta-cell and alpha-cell function in African-American children with type 2 diabetes mellitus--"Flatbush diabetes".J Pediatr Endocrinol Metab. 2002 Apr;15 Suppl 1:493-501. J Pediatr Endocrinol Metab. 2002. PMID: 12017222 Review.
-
Toward an integrated phenotype in pre-NIDDM.Diabet Med. 1996 Sep;13(9 Suppl 6):S67-77. Diabet Med. 1996. PMID: 8894486 Review.
Cited by
-
Duodenal-jejunal bypass liner to treat type 2 diabetes mellitus in morbidly obese patients.Curr Cardiol Rep. 2014 Mar;16(3):454. doi: 10.1007/s11886-013-0454-3. Curr Cardiol Rep. 2014. PMID: 24570355 Review.
-
A Prospective Study of Variability in Glycemic Control during Different Phases of the Menstrual Cycle in Type 2 Diabetic Women Using High Sensitivity C - Reactive Protein.J Clin Diagn Res. 2014 Apr;8(4):CC01-4. doi: 10.7860/JCDR/2014/8118.4240. Epub 2014 Apr 15. J Clin Diagn Res. 2014. PMID: 24959437 Free PMC article.
-
Efficacy of glimepiride/metformin fixed-dose combination vs metformin uptitration in type 2 diabetic patients inadequately controlled on low-dose metformin monotherapy: A randomized, open label, parallel group, multicenter study in Korea.J Diabetes Investig. 2014 Nov;5(6):701-8. doi: 10.1111/jdi.12201. Epub 2014 Mar 16. J Diabetes Investig. 2014. PMID: 25422771 Free PMC article.
-
No evidence for association of the ENPP1 (PC-1) K121Q variant with risk of type 2 diabetes in a Japanese population.J Hum Genet. 2006;51(6):559-566. doi: 10.1007/s10038-006-0399-0. Epub 2006 Apr 11. J Hum Genet. 2006. PMID: 16607460
-
Enhanced cortisol production rates, free cortisol, and 11beta-HSD-1 expression correlate with visceral fat and insulin resistance in men: effect of weight loss.Am J Physiol Endocrinol Metab. 2009 Feb;296(2):E351-7. doi: 10.1152/ajpendo.90769.2008. Epub 2008 Dec 2. Am J Physiol Endocrinol Metab. 2009. PMID: 19050176 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical